ITERUM THERAPTC Revenue, Profits - ITRM Quarterly Income Statement

Add to My Stocks
$6.71 $0.78 (10.41%) ITRM stock closing price Sep 24, 2018 (Closing)

ITRM stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the ITERUM THERAPTC stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $- for 2018 Q2 impacts the ITRM stock. Investors typically check year over year or quarter over quarter revenue growth. Revenue for year 2018 Q2 is $- and has decreased from $- quarter on quarter as is evident when you compare the latest figures in the latest ITERUM THERAPTC profit and loss statement with those of the prior corresponding period. Also see ITERUM THERAPTC assets and ITERUM THERAPTC free cash flow for a complete valuation of ITRM stock.

View and download details of revenue and profits for ITERUM THERAPTC for latest & last 40 quarters.
show more
Fiscal year is Jan - Dec2018 Q22017 Q2
ITERUM THERAPTC Revenues or Net Sales
--
Cost Of Goods Sold (COGS)--
ITERUM THERAPTC Gross Profit
--
Research & Development Expense13.72M5.29M
Selling General & Admin Expense1.88M1.12M
Income Before Depreciation Depletion Amortization-15.42M-6.41M
Depreciation Depletion Amortization--
Non Operating Income-0.25M-
Interest Expense--
ITERUM THERAPTC Pretax Income
-15.67M-6.2M
Provision for Income Taxes--
MinorityInterest--
Investment Gains Losses--
Other Income--
Income Before Extraordinaries & Disc Operations-15.75M-6.28M
Extraordinary Items & Discontinued Operations--
ITERUM THERAPTC Profit/ Loss (Net Income)
-15.75M-6.28M
Average Shares used to compute Diluted EPS7.09M-
Average Shares used to compute Basic EPS7.09M-
Income Before Nonrecurring Items-15.75M-
Income from Nonrecurring Items--
ITERUM THERAPTC Earnings Per Share Basic Net
-2.22-
ITERUM THERAPTC Earnings Per Share Diluted Net
-2.22-
EPS Diluted Before Nonrecurring Items-2.22-
Preferred Dividends Acc Pd--
Dividends Common0.00-
Dividend Per Share Common0.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

ITERUM THERAPTC stock analysis involves checking at least a few of the important things like:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: ITERUM THERAPTC revenue chart, implies that the company is growing. It has not been the case with ITERUM THERAPTC. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like ITERUM THERAPTC try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the ITRM income statement, one can check the ITERUM THERAPTC historical stock prices to check how the price has moved with time.

ITERUM THERAPTC Income Statement - Key Financial Ratios

Dividend Yield
0%

Other Income Statements - ITERUM THERAPTC Industry Peers

Infinity Pharma income statement, Steadymed income statement